A short-chain α-neurotoxin from Naja naja atra produces potent cholinergic-dependent analgesia

Neuroscience Bulletin

Volumn 22, Issue 2, 2006, Pages 103-109

  Zhang, Hui Ling ^a   Han, Rong ^a   Gu, Zhen Lun ^a   Chen, Zhi Xing ^a   Chen, Bo Wen ^a   Reid, Paul F ^b   Raymond, Laurence N ^b   Qin, Zheng Hong ^a  

^a SOOCHOW UNIVERSITY   (China)

^b ReceptoPharm Inc   (United States)

Author keywords

Analgesia; Atropine; Cobrotoxin; Naloxone; Periaqueductal gray matter

Indexed keywords

ALPHA NEUROTOXIN; ATROPINE; COBROTOXIN; NALOXONE; NEUROTOXIN; SNAKE VENOM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; FEMALE; MALE; MOUSE; NAJA NAJA ATRA; NONHUMAN; PAIN; SNAKE;

EID: 33847780532     PISSN: 16737067     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Yang CC. Cobrotoxin: structure and function. J Natural Toxins, 1999, 8: 221-233.
2. Servent D, Anti-Delbeke S, Gaillard C, et al. Molecular characterization of the specificity of interactions of various neurotoxins on two distinct nicotinic acetylcholine receptors. European J Pharmacol, 2000, 393: 197-204.
3. Dajas-Bailador F, Costa G, Dajas F, et al. Effects of α-bungarotoxin, α-cobratoxin and fasciculin on the nicotine-evoked release of dopamine in the rat striatum in vivo. Neurochem Intl, 1998, 33: 307-312.
4. Zeng HY, Hawrot E. NMR-based binding screen and structural analysis of the complex formed between-α cobratoxin and an 18-Mer cognate peptide derived from the α1 subunit of the nicotinic acetylcholine receptor from Torpedo californica. J Biol Chem, 2002, 277: 37439-37445.
5. Chen R, Robinson SE. Effect of cholinergic manipulations on the analgesic response to cobrotoxin in mice. Life Sci, 1990, 47: 1949-1954.
6. Pu XC, Wong PT, Gopalakrishnakone P. A novel analgesic toxin (hannalgesin) from the venom of king cobra (Ophiophagus hannah). Toxicon, 1995, 33: 1425-1431.
7. Adriana CM, Andreimar MS, Silvia HAE, et al. The analgesic activity of crotamine, a neurotoxin from crotalus durissus terrificus (South American rattlesnake) venom: a biochemical and pharmacological study. Toxicon, 1998, 36: 1927-1937.
8. Cura JE, Blanzaco DP, Brisson C, et al. Phase I and pharmacokinetics study of crotoxin (cytotoxin PLA2, NSC-624244) in patient with advanced cancer. Clin Cancer Res, 2002, 8: 1033-1041.
9. Pedigo NW, Dewey WI, Harris LS. Determination and characterization of the antinociceptive activity of intraventricularly administered acetylcholine in mice. J Pharmacol Exp Ther, 1975, 193: 845-852.
10. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Academic Press (2 ed), 1986: 45-51.
11. Yaksh TL, Yeung JC, Rudy TA. Systematic examination in the rat of brain sites sensitive to the direct application effects with the periaqueductal gray. Brain Res, 1976, 114: 1183-1188.
12. Jensen TS, Yaksh TL. Comparison of antinococeptive action of morphine in the periaqueductal gray, medial and puramedial medulla in rat. Brain Res, 1986, 363:99-113.
13. Harris LS, Dewey WL. Role of cholinergic systems in the central action of narcotic agonists and antagonists. In: Kosterlitz HW, Collier HOJ, Villareal JE (Eds), Agonist and antagonist actions of narcotic analgesic drugs. London:Macmillan. 1972: 198-206.
14. Giorgi R, Bernardi MM, Cury Y. Analgesic effect evoked by low molecular weight substances extracted from Crotalus durissus terrificus venom. Toxicon, 1993, 31:1257-1365.
15. Rudd CJ, Viskatis LJ, Vidal JC, et al. In vitro comparison of cytotoxic effects of crotoxin against three human tumors and normal human epidermal keratinocyte cell line. Invest New Drugs, 1994, 12: 183-184.
16. Conn RE, Viskatis LJ, Vidal JC, et al. Cytotoxicity of crotoxin on murine erythroleukemia cells in vitro. Invest New Drugs, 1993, 11:11-15.
17. Tseng LF, Chiu TH, Lee CY, Absorption and distribution of I-labeled cobra venom and its purified toxins. Tox Applied Pharmacol, 1968, 12: 526-535.
18. Decker MW, Meyer MD, Sullivan JP. The therapeutic potential of nicotinic acetylcholine receptor agonists for pain control. Expert Opin Investig Drugs,2001, 10:1819-1830.
19. Damaj MI, Meyer EM, Martin BR. The antinociceptive effects of alpha7 nicotinic agonists in an acute pain model. Neuropharmacology, 2000, 39:2785-2791.
20. Shiraishi M, Minami K, Uezono Y, et al. Inhibitory effects of tramadol on nicotinic acetylcholine receptors in adrenal chromaffin cells and in Xenopus oocytes expressing alpha7 receptors. Br J Pharmacol, 2002, 136: 207-216.
21. Irnaten M, Wang J, Venkatesan P, et al. Ketamine inhibits presynaptic and postsynaptic nicotinic excitation of identified cardiac parasympathetic neurons in nucleus ambiguous. Anesthesiology, 2002, 96:667-674.
22. Xiong Y, Wand W, Pu X, et al. Preliminary study on the mechanism of using snake venoms to substitute for morphine. Toxicon, 1992, 30: 567.
23. Grasset E. The cobra neurotoxin; pharmacology and clinical applications in the treatment of pain. Med Hyg (Geneve) , 1952, 10: 55-58.
24. Chen ZX, Zhang HL, Han R, et al. A long chain α-neurotoxin from Thailand cobra venom produces potent opioid-independent analgesia. Acta Pharmacol Sinica, 2006, 27:1-7.